The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hepatic artery infusion chemotherapy (HAIC) combined with sintilimab and bevacizumab biosimilar (IBI305) for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial.
 
Dongming Liu
No Relationships to Disclose
 
Han Mu
No Relationships to Disclose
 
Changfu Liu
No Relationships to Disclose
 
Weihao Zhang
No Relationships to Disclose
 
Yunlong Cui
No Relationships to Disclose
 
Qiang Wu
No Relationships to Disclose
 
Xiaolin Zhu
No Relationships to Disclose
 
Feng Fang
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Wenge Xing
No Relationships to Disclose
 
Qiang Li
No Relationships to Disclose
 
Tianqiang Song
No Relationships to Disclose
 
Wei Lu
No Relationships to Disclose
 
Huikai Li
No Relationships to Disclose